Tuba Ersal

14PUBLICATIONS
60CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyMajor global burdens of diseaseHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 12, 2026
Management of Rituximab-Associated Hypersensitivity Reactions with Successfully Applied Desensitization Protocols: A Clinical Experience of 46 Infusions in 11 Patients.

|Jun 04, 2026
Clinical outcomes and prognostic factors in hematologic malignancy patients with probable CMV pneumonia.

|Mar 14, 2026
The Dynamic Endothelial Activation and Stress Index (EASIX) as a Predictor of Early Death and Long-Term Survival in Acute Promyelocytic Leukemia (APL): A Multicenter Study.

Fazıl Çağrı Hunutlu, Vildan Özkocaman, Mehmet Baysal

|Dec 11, 2025
Predicting Bleeding in AML-Associated DIC: Limitations of the ISTH Score and a Modified Approach.

Bedrettin Orhan, Fahir Özkalemkaş, Tuba Bayır

|Oct 16, 2025
Viable and Functional: Long-Term -80 °C Cryopreservation Sustains CD34+ Integrity and Transplant Success.

Ibrahim Ethem Pinar, Muge Sahin, Vildan Gursoy

|Oct 16, 2025
Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group.

Emel Isleyen, Nurcan Alhan, Esra Terzi Demirsoy

Pageof 3

Frequent Collaborators

13 joint publications

Fahir Özkalemkaş

10 joint publications

Fazıl Çağrı Hunutlu

5 joint publications

Vildan Özkocaman

4 joint publications

Cumali Yalçın